Personal tools

Sponsorname

Your company could advertise here

www.fla-consulting.eu

Glossary:TAG-00343-Doc-ten

From GxPlex

Revision as of 17:29, 15 July 2026 by imported>GxPlexBot (Import from GxPlex Excel)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search


Glossary > Documentation

Documentation
Tag-ID TAG-00343-Doc-ten
English Documentation / Trial documentation / Study documentation / Document management / Recordkeeping / Record management / Document control
French Documentation / Documentation de l'essai / Documentation de l'ĂŠtude / Gestion des documents / Tenue des dossiers / Gestion des enregistrements / ContrĂ´le des documents
German Dokumentation / Studiendokumentation / PrĂźfungsdokumentation / Dokumentenverwaltung / AktenfĂźhrung / Unterlagenverwaltung / Dokumentenkontrolle

References

 ScopeDocument partLanguageDocument
AUT Ärztegesetz 08-Mar-2023 § 51 (3)G§ 51 (3)DEAUT Ärztegesetz 08-Mar-2023
DEU AMWHV – Arzneimittel- und Wirkstoffherstellungs-verordnung 09-Aug-2019 § 20HM§ 20DEDEU AMWHV – Arzneimittel- und Wirkstoffherstellungs-verordnung 09-Aug-2019
DEU BGB - Bßrgerliches Gesetzbuch 22-Dec-2023 § 630G§ 630DEDEU BGB - Bßrgerliches Gesetzbuch 22-Dec-2023
DEU Bundestag - Sachstand zur Aufbewahrung von Patientenakten in der ambulanten Praxis Fristen und Form 01-Mar-2021 -G-DEDEU Bundestag - Sachstand zur Aufbewahrung von Patientenakten in der ambulanten Praxis Fristen und Form 01-Mar-2021
DEU DGEPi - GEP Guter Epidemiologischer Praxis Sep-2018 Leitlinie 3 3.7NISLeitlinie 3 3.7DEDEU DGEPi - GEP Guter Epidemiologischer Praxis Sep-2018
DEU DGEPi - GEP Guter Epidemiologischer Praxis Sep-2018 Leitlinie 7NISLeitlinie 7DEDEU DGEPi - GEP Guter Epidemiologischer Praxis Sep-2018
DEU Gemeinsame Empfehlungen - zur Anzeige von Anwendungsbeobachtungen und nichtinterventionellen Unbedenklichkeits-studien 15-Dec-2022 2.2.1 - EndeNIS2.2.1 - EndeDEDEU Gemeinsame Empfehlungen - zur Anzeige von Anwendungsbeobachtungen und nichtinterventionellen Unbedenklichkeits-studien 15-Dec-2022
DEU Gemeinsame Empfehlungen - zur Anzeige von Anwendungsbeobachtungen und nichtinterventionellen Unbedenklichkeits-studien 15-Dec-2022 2.2.1 - StartNIS2.2.1 - StartDEDEU Gemeinsame Empfehlungen - zur Anzeige von Anwendungsbeobachtungen und nichtinterventionellen Unbedenklichkeits-studien 15-Dec-2022
DEU MBO - Berufsordnung der Ärzt:innen 11-Jun-2021 § 10 Absatz 3G§ 10 Absatz 3DEDEU MBO - Berufsordnung der Ärzt:innen 11-Jun-2021
DEU MPDG - Medizinprodukterecht-Durchfßhrungsgesetz 28-Jun-2022 § 33 Absatz 2MD§ 33 Absatz 2DEDEU MPDG - Medizinprodukterecht-Durchfßhrungsgesetz 28-Jun-2022
EU EMA/431265/2016 Annex I – to guidance for the conduct of good clinical practice inspections – investigator site 06-Sep-2017 4.G4.ENEU EMA/431265/2016 Annex I – to guidance for the conduct of good clinical practice inspections – investigator site 06-Sep-2017
EU EMA/INS/GCP/143492/2022 - ANNEX I TO PROCEDURE FOR CONDUCTING GCP INSPECTIONS REQUESTED BY THE CHMP: INVESTIGATOR SITE 2022 Page 6GPage 6ENEU EMA/INS/GCP/143492/2022 - ANNEX I TO PROCEDURE FOR CONDUCTING GCP INSPECTIONS REQUESTED BY THE CHMP: INVESTIGATOR SITE 2022
EU EMA/INS/GCP/856758/ 2018 Guideline on the content, management and archiving of the clinical trial master file (paper and/or electronic) 06-Dec-2018 3.5.2G3.5.2ENEU EMA/INS/GCP/856758/ 2018 Guideline on the content, management and archiving of the clinical trial master file (paper and/or electronic) 06-Dec-2018
EU EMA/INS/GCP/856758/ 2018 Guideline on the content, management and archiving of the clinical trial master file (paper and/or electronic) 06-Dec-2018 3.5.3G3.5.3ENEU EMA/INS/GCP/856758/ 2018 Guideline on the content, management and archiving of the clinical trial master file (paper and/or electronic) 06-Dec-2018
EU Eudralex - volume 4 GMP Guidelines Chapter 4 Jan-2011 4G4ENEU Eudralex - volume 4 GMP Guidelines Chapter 4 Jan-2011
EU Recommendations of the expert group - Risk proportionate approaches in clinical trials 25-Apr-2017 4.5HM4.5ENEU Recommendations of the expert group - Risk proportionate approaches in clinical trials 25-Apr-2017
EU Regulation (EU) 2017/745 - Medical Device Regulation 20-Mar-2023 Annex XV Chapter II Section 1.7MDAnnex XV

Chapter II

Section 1.7
ENEU Regulation (EU) 2017/745 - Medical Device Regulation 20-Mar-2023
EU Regulation (EU) 2017/745 - Medical Device Regulation 20-Mar-2023 Annex XV Chapter III 1. ; 3.MDAnnex XV

Chapter III

1. ; 3.
ENEU Regulation (EU) 2017/745 - Medical Device Regulation 20-Mar-2023
EU Regulation (EU) 2017/745 - Medical Device Regulation 20-Mar-2023 Annex XV Chapter III Paragraph 3MDAnnex XV

Chapter III

Paragraph 3
ENEU Regulation (EU) 2017/745 - Medical Device Regulation 20-Mar-2023
EU Regulation (EU) 2017/745 - Medical Device Regulation 20-Mar-2023 Article 72 Paragraph 3 – 4-001MDArticle 72 Paragraph 3 – 4ENEU Regulation (EU) 2017/745 - Medical Device Regulation 20-Mar-2023
EU Regulation (EU) 2017/745 - Medical Device Regulation 20-Mar-2023 Article 72 Paragraph 3 – 4-002MDArticle 72 Paragraph 3 – 4ENEU Regulation (EU) 2017/745 - Medical Device Regulation 20-Mar-2023
EU Regulation (EU) 2017/746 - in vitro diagnostic medical devices 20-Mar-2023 Annex XIV Chapter I Section 1.8IVDAnnex XIV

Chapter I

Section 1.8
ENEU Regulation (EU) 2017/746 - in vitro diagnostic medical devices 20-Mar-2023
EU Regulation (EU) 2017/746 - in vitro diagnostic medical devices 20-Mar-2023 Annex XIV Chapter II Section 3-001IVDAnnex XIV

Chapter II

Section 3
ENEU Regulation (EU) 2017/746 - in vitro diagnostic medical devices 20-Mar-2023
EU Regulation (EU) 2017/746 - in vitro diagnostic medical devices 20-Mar-2023 Annex XIV Chapter II Section 3-002IVDAnnex XIV

Chapter II

Section 3
ENEU Regulation (EU) 2017/746 - in vitro diagnostic medical devices 20-Mar-2023
EU Regulation (EU) 2017/746 - in vitro diagnostic medical devices 20-Mar-2023 Article 68 Paragraph 3 – 4-001IVDArticle 68 Paragraph 3 – 4ENEU Regulation (EU) 2017/746 - in vitro diagnostic medical devices 20-Mar-2023
EU Regulation (EU) 2017/746 - in vitro diagnostic medical devices 20-Mar-2023 Article 68 Paragraph 3 – 4-002IVDArticle 68 Paragraph 3 – 4ENEU Regulation (EU) 2017/746 - in vitro diagnostic medical devices 20-Mar-2023
EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 ANNEX I Section K No. 59-60HMANNEX I

Section K

No. 59-60
ENEU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022
EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 56HMArticle 56ENEU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022
FRA DHOS/E1/DAF/DPACI no 2007-322 14-Aug-2007 2.1G2.1FRFRA DHOS/E1/DAF/DPACI no 2007-322 14-Aug-2007
FRA DHOS/E1/DAF/DPACI no 2007-322 14-Aug-2007 2.1.2G2.1.2FRFRA DHOS/E1/DAF/DPACI no 2007-322 14-Aug-2007
ICH ICH E6 Guideline R3 (2025) Appendix B 14.3GAppendix B 14.3ENICH ICH E6 Guideline R3 (2025)
ISO ISO 14155 - Clinical investigation of medical devices for human subjects 2020 7.4.3-001MD7.4.3ENISO ISO 14155 - Clinical investigation of medical devices for human subjects 2020
ISO ISO 14155 - Clinical investigation of medical devices for human subjects 2020 7.4.3-002MD7.4.3ENISO ISO 14155 - Clinical investigation of medical devices for human subjects 2020
USA 21 CFR Part 312 09-Apr-2025 § 312.57-001HM§ 312.57ENUSA 21 CFR Part 312 09-Apr-2025
USA 21 CFR Part 312 09-Apr-2025 § 312.57-002HM§ 312.57ENUSA 21 CFR Part 312 09-Apr-2025
USA 21 CFR Part 312 09-Apr-2025 § 312.62HM§ 312.62ENUSA 21 CFR Part 312 09-Apr-2025
USA 21 CFR Part 312 09-Apr-2025 § 312.62 (c)HM§ 312.62 (c)ENUSA 21 CFR Part 312 09-Apr-2025
USA 21 CFR Part 54 09-Apr-2025 § 54.6G§ 54.6ENUSA 21 CFR Part 54 09-Apr-2025
USA 21 CFR Part 812 09-Apr-2025 Subpart GMDSubpart GENUSA 21 CFR Part 812 09-Apr-2025
USA 21 CFR Part 812 09-Apr-2025 § 812.140 (a) (3) (ii)MD§ 812.140 (a) (3) (ii)ENUSA 21 CFR Part 812 09-Apr-2025
USA 21 CFR Part 812 09-Apr-2025 § 812.140 (b) (5)MD§ 812.140 (b) (5)ENUSA 21 CFR Part 812 09-Apr-2025
USA 45 CFR Part 160 09-Apr-2025 § 164.526G§ 164.526ENUSA 45 CFR Part 160 09-Apr-2025
USA 45 CFR Part 46 09-Apr-2025 § 46.115G§ 46.115ENUSA 45 CFR Part 46 09-Apr-2025
USA FDA - HUMAN DRUG CGMP NOTES Volume 8, Number 3 6G6ENUSA FDA - HUMAN DRUG CGMP NOTES Volume 8, Number 3
WHO WHO - EXPERT COMMITTEE ON SPECIFICATIONS FOR PHARMACEUTICAL PREPARATIONS Forty-fifth report -G-ENWHO WHO - EXPERT COMMITTEE ON SPECIFICATIONS FOR PHARMACEUTICAL PREPARATIONS Forty-fifth report
WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995 8HM8ENWHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995